Pharmacy Practice & Science Department Highlights: March 2023
Publications
iVO ABRAHAM
Abraham I, Calamia M, MacDonald KM. Should a systematic review be required in a clinical trial report? Perhaps, but not yet. JAMA Network Open 2023;6:e234226.
Yousef CC, Khan MA, Almodaimegh H, Alshamrani M, Al-Foheidi MO, AlAbdalkarim H, AlJedai A, Naeem A, Abraham I. Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ breast cancer treatment in Saudi Arabia: simulation study. Journal of Medical Economics 2023;26:394-402.
AlLehaibi LH, Alomar M, Almulhim A, Al-Makki S, Alrwaili NR, Al-Bassam S, Alsultan S, Al Saeed J, Alsheef M, Abraham I, Alamer A. Effectiveness and safety of enoxaparin versus unfractionated heparin as thromboprophylaxis in COVID-19 patients: real-world evidence. Annals of Pharmacotherapy 2023;57:361-374.
Abraham I. The 2022 WHO guidelines on biosimilars: loosening the reins or changing the track? Part 2. Center for Biosimilars (column). https://www.centerforbiosimilars.com/view/dr-ivo-abraham-column-the-2022...
Abraham I. The 2022 WHO guidelines on biosimilars: loosening the reins or changing the track? Part 1. Center for Biosimilars (column). https://www.centerforbiosimilars.com/view/dr-ivo-abraham-column-the-2022...
Abraham I, Lee KKC, Gregg M. Journal of Medical Economics in review: high impact articles from 2022. Journal of Medical Economics 2023;23:303-307.
Oh M, McBride A, Bhattacharjee S, Slack M, Jeter J, Abraham I. Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment. Expert Review of Pharmacoeconomics and Outcomes Research 2023;23:297-325.
Oh M, McBride A, Bhattacharjee S, Slack M, Jeter J, Abraham I. Economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention. Expert Review of Pharmacoeconomics and Outcomes Research 2023;23:309-316.
Oh M, McBride A, Bhattacharjee S, Slack M, Jeter J, Abraham I. Economic value of knowing BRCA status: BRCA testing for optimizing treatment in recurrent epithelial ovarian cancer. Expert Review of Pharmacoeconomics and Outcomes Research 2023;23:317-325.
Jennifer BINGHAM
Aqel O, Alqadheeb B, Amundson C, Bingham J, Meyer K, Warholak T, Axon D. Cultivating COVID-19 Vaccine Confidence in Pharmacy Professionals. Pharmacy. 2023. 11(2):50.
BONNIE LAFLEUR
LaFleur, B., Curiel-Lewandrowski, C., Tapia, E., Parker, J., White, L., Chow, H. S., & South, A. P. (2023). Characterizing Dermal Transcriptional Change in the Progression from Sun-Protected Skin to Actinic Keratosis. The Journal of investigative dermatology, S0022-202X.
Presentations
iVO ABRAHAM
Abraham I, Al Rawashdh N. Economic evaluation of trajectories of cancer treatments. Invited Lecture, Hail University, Hail, Saudi Arabia (virtual)
Jennifer BINGHAM
Dr. Jennifer Bingham was featured as a guest speaker on the Salus Vitae series, The Questions We Pursue. She was invited to present her research and how we can support clinicians with readiness tools to prepare for the provision of care via telehealth and digital health. To watch: https://youtu.be/qHrH2T9V2N0
ASHLEY CAMPBELL
Gave an AACP Webinar on 3/15/23 Title: 'Teaching To, For, and With Multiple Generations' Co-Presenters from the AACP Geriatrics Special Interest Group
Served as a panelist for the Virtual Town Hall on Senior Health Hosted by Banner Health and the Pima County Health Department
Co-panelists included:
Dr. Theresa Cullen, Director of the Pima County Health Department
Dr. Mindy Fain, Chief of the Division of Geriatrics
Dr. Allan Anderson, Director of the Alzheimer's Research Institute Tucson
Mark Clark, President of the Pima Council on Aging
Awards
iVO ABRAHAM
Fellow, Association of Community Cancer Centers (FACCC)
JOHN MURPHY
Dr. Murphy has been named Distinguished Alumnus and will deliver the commencement presentation at the University of Florida this May.
Grants
Thymic and peripheral Aspects of T cell Aging and Rejuvenation (P01AG052359-06A1). Director-Data Sciences Core.